You are here: Industry Insights > COVID-19

News List

NIH-sponsored trials evaluate monoclonal antibodies for Covid-19 treatment pharmaceutical-technology
December 18, 2020
The National Institutes of Health (NIH) in the US has announced the initiation of two Phase III clinical trials analysing investigational monoclonal antibodies for treating people hospitalised with moderate Covid-19.
Open Care announces Immubio platform based on nanoparticle science, currently developing potential break-through COVID-19 immunisation prnasia
December 18, 2020
Open Care have announced the progress of their early-stage development of their potential COVID-19 Immunisation, ImmubioCV, based on Nanobiologics, a new approach centered on nanoparticles, water coherent domains and ultra dilutions that allows for the ..
Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals prnasia
December 18, 2020
Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in a gold standard ferret study, has been published in two leading international peer-reviewed journals.
ACE2 protein protects against severe COVID-19 worldpharmanews
December 18, 2020
Female COVID-19 patients face less severe disease complications and a lower risk of dying than male patients thanks to hormones and chromosomes that contribute to a stronger immune response, according to new research from a University of Alberta-led team.
CHOP Researchers Receive Funding to Study Effects of COVID-19 on Preterm Birth prnewswire
December 18, 2020
Researchers at Children's Hospital of Philadelphia (CHOP) have formed a new consortium that will study the effects of the COVID-19 pandemic on preterm birth and prenatal care, funded by $300,000 in grants from the Independence Blue Cross Foundation ...
CN Bio, University of Melbourne collaborate to advance therapies for respiratory complications in recovered Covid-19 patients pharmaceutical-business-review
December 18, 2020
CN Bio announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients.
First hospitalised COVID-19 patient dosed in FSD201 treatment trial europeanpharmaceuticalreview
December 18, 2020
The study will evaluate whether FSD201 is safe and of benefit to hospitalised patients with COVID-19, in combination with standard of care.
International consortium creates ‘open platform’ for COVID-19 drug discovery pharmatimes
December 18, 2020
An international consortium, led by Cambridge Medical Research Council (MRC) researchers, has developed an ‘open platform’ to advance and prioritise drug discovery and repurposing efforts for COVID-19.
EUSA Pharma launches phase III COVID-19 study for siltuximab pharmatimes
December 18, 2020
UK-headquartered EUSA Pharma has enrolled the first patient in a phase III study of siltuximab in patients hospitalised with COVID-19.
Therapeutic Solutions Announces Positive QuadraMune Clinical Trial Data americanpharmaceuticalreview
December 18, 2020
Therapeutics Solution International announced new data from its clinical trial demonstrating an almost doubling of immune cell activity in healthy volunteers which were ingesting QuadraMune? daily for a week.